Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026

Definium Therapeutics Inc. (DFTX) — NEW YORK, October 29, 2026--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a webcast at 4:30 p.m. EST on Monday, November 9, 2026 to report financial results for the third quarter ended September 30, 2026, and discuss recent business highlights.

Source: Business Wire — read the full announcement there.

Browse more sector announcements in our press release archive.